Physician profile
David Alexander Kretch
NPI 1386026474
$3,365.70
in general payments reported to CMS, 2019-2025
35 companies · $13.75 in 2025
The $13.75 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $1,107 · 2021: $486 · 2022: $645 · 2023: $455 · 2024: $162 · 2025: $13.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $948.29 | 2019-2025 | Renasys Go V2 Home, Grafix, Stravix Pl |
| Stryker Corporation | $644.97 | 2019-2023 | Prophecy |
| Horizon Therapeutics Plc | $219.33 | 2020-2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $174.32 | 2019-2021 | |
| Organogenesis INC. | $158.88 | 2019-2024 | Puraply |
| Grt US Holding, INC. | $152.32 | 2022 | |
| Cardiovascular Systems INC. | $138.83 | 2020 | |
| Averitas Pharma INC. | $109.80 | 2023-2024 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.34 | 2022 | |
| Paratek Pharmaceuticals, INC. | $81.49 | 2020-2022 | |
| Bioventus LLC | $79.92 | 2019-2022 | |
| Nevro Corp. | $67.98 | 2023 | Senza |
| Triad Life Sciences INC. | $40.65 | 2022 | |
| Medtronic, INC. | $31.47 | 2023 | Hawkone, Intellis Adaptivestim |
| Paragon 28, INC. | $30.30 | 2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $28.79 | 2019 | |
| Anika Therapeutics, INC. | $26.50 | 2022 | |
| Acell, INC. | $26.09 | 2019-2020 | |
| Abbott Laboratories | $24.11 | 2020 | |
| Treace Medical Concepts, INC. | $23.62 | 2022 | |
| Amgen INC. | $21.13 | 2024 | Krystexxa |
| Ani Pharmaceuticals, INC. | $20.77 | 2024 | Purified Cortrophin Gel |
| Cashflow Solutions, LLC | $20.59 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Integra Lifesciences Corporation | $20.40 | 2019 | |
| Melinta Therapeutics, LLC | $20.08 | 2019 | |
| Orthofix Medical, INC. | $19.72 | 2019 | |
| Assertio Therapeutics, INC. | $19.00 | 2020 | |
| Ibsa Pharma INC. | $18.77 | 2023 | Tirosint, Licart |
| Mimedx Group, INC. | $18.11 | 2024 | |
| Nabriva Therapeutics, Plc | $17.60 | 2020 | |
| Arteriocyte Medical Systems, INC. | $15.49 | 2020 | |
| Convatec INC. | $14.89 | 2023 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 | |
| Novum Pharma, LLC | $11.91 | 2019 | |
| Kerecis Limited | $7.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kretch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.